Olema Pharmaceuticals, Inc. (OLMA): Submission of Matters to a Vote of Security Holders
Olema Pharmaceuticals, Inc. (OLMA) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. 8-K false 0001750284 0001750284 2026-06-17 2026-06-17 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 17,
How this was made
The 30-second read
Why it matters
The disclosure confirms stockholder approval of the slate of directors, an advisory vote on executive compensation, and ratification of Ernst & Young LLP as independent auditor for 2026.
Market read
This is a procedural governance update; it does not introduce new operating, financial, or regulatory catalysts.
What to watch
Vote counts (including broker non-votes) can matter for governance narratives, but the 8-K does not indicate any failed proposal or contested control change.
Background
The company filed an SEC Form 8-K (Item 5.07) reporting matters submitted to a vote of security holders at its June 17, 2026 annual meeting.
Ticker impact
Olema Pharmaceuticals reported 2026 annual meeting voting results, including director elections, executive compensation approval, and EY ratification.
Low likelihood of a sustained price move based solely on these voting tallies.
The filing is an 8-K Item 5.07 summarizing votes (directors, advisory comp, auditor ratification) without new financial guidance, transactions, or regulatory actions.
Market effects
Minimal; governance vote results do not reset sector expectations.
Minimal; no cross-border transaction or macro linkage described.
Minimal; filing is company-specific and procedural.
Counterpoint
If investors were concerned about governance or auditor continuity, the ratification and approvals could reduce overhang, but the filing provides no evidence of a contested outcome.
Key entities
- issuerOlema Pharmaceuticals, Inc.
Nasdaq-listed company filing the 8-K with annual meeting voting results.
- auditorErnst & Young LLP
Ratified by stockholders as independent registered public accounting firm for year ending Dec. 31, 2026.
